Clinical trial
Clinical Research of Double Filtration Plasmapheresis Combined With Chemotherapy to Remove M Protein in Multiple Myeloma
NCT04836871 is registered in ClinicalTrials.gov with Fuling Zhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Research of Double Filtration Plasmapheresis Combined With Chemotherapy to Remove M Protein in Multiple Myeloma
- Lead sponsor
- Fuling Zhou
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- May 15, 2021
- Completion date
- October 31, 2024
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.